| BMP4 |
BMP4, BMP2B, DVR4: Bone morphogenetic protein 4 precursor |
BMP5 |
BMP5: Bone morphogenetic protein 5 precursor |
2.177 |
Evidence |
|
| PIM1 |
IPI00005014 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
2.177 |
Evidence |
|
| PTPRF |
PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor |
PTPRD |
PTPRD: Protein tyrosine phosphatase receptor type D |
2.177 |
Evidence |
|
| HTR1A |
HTR1A, ADRB2RL1, ADRBRL1: 5-hydroxytryptamine receptor 1A |
FAM62A |
FAM62A, KIAA0747, MBC2: Protein FAM62A |
2.177 |
Evidence |
|
| KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
KLK2 |
KLK2: Kallikrein-2 precursor |
2.177 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PIM1 |
IPI00005014 |
2.177 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
KLK2 |
KLK2: Kallikrein-2 precursor |
2.177 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
KLK4 |
KLK4, EMSP1, PRSS17, PSTS: Kallikrein-4 precursor |
2.177 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
LRP11 |
LRP11: Low-density lipoprotein receptor-related protein 11 precursor |
2.177 |
Evidence |
|
| CCNE2 |
CCNE2: G1/S-specific cyclin-E2 |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
2.177 |
Evidence |
|
| CCNE2 |
CCNE2: G1/S-specific cyclin-E2 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
2.177 |
Evidence |
|
| PARN |
PARN, DAN: Poly(A)-specific ribonuclease PARN |
TIA1 |
TIA1: Nucleolysin TIA-1 isoform p40 |
2.177 |
Evidence |
|
| OR2C1 |
OR2C1, OR2C2P: Olfactory receptor 2C1 |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
2.177 |
Evidence |
|
| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
2.177 |
Evidence |
|
| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
CCNE1 |
CCNE1, CCNE: G1/S-specific cyclin-E1 |
2.177 |
Evidence |
|
| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
2.177 |
Evidence |
|
| PRKD3 |
PRKD3, EPK2, PRKCN: Serine/threonine-protein kinase D3 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
2.177 |
Evidence |
|
| RPS6KA4 |
RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
2.177 |
Evidence |
|
| RPS6KA4 |
RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 |
NUP50 |
NUP50, NPAP60L, PRO1146: Nucleoporin 50 kDa |
2.177 |
Evidence |
|
| RPS6KA4 |
RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 |
PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
2.177 |
Evidence |
|
| BRD4 |
IPI00440727 |
CBX1 |
CBX1, CBX: Chromobox protein homolog 1 |
2.177 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
DOK3 |
IPI00156649 |
2.177 |
Evidence |
|
| SORBS3 |
SORBS3, SCAM1: Vinexin |
DUSP10 |
DUSP10, MKP5: Dual specificity protein phosphatase 10 |
2.177 |
Evidence |
|
| ZFHX1B |
Zinc finger homeobox protein 1b |
ZFPM1 |
ZFPM1, FOG1: Zinc finger protein ZFPM1 |
2.177 |
Evidence |
|
| XPOT |
XPOT: Exportin-T |
RANBP2 |
RANBP2, NUP358: E3 SUMO-protein ligase RanBP2 |
2.177 |
Evidence |
O
|